Anzeige
Mehr »
Login
Mittwoch, 12.03.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
KI-Revolution trifft Immobilienmarkt: Pioneers Partner Nabo zielt auf einen 2-Billionen-Dollar-Markt ab!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
737 Leser
Artikel bewerten:
(2)

Capstone Holding Corp. Announces Change in Board of Directors

Finanznachrichten News

ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company")

Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. from its board of directors. The Company thanks Mssrs. Feldman and Howse for their many years of dedicated and valuable service.

John M. Holliman, III, will assume the lead independent director role and will serve as Chairman of the Company's Audit Committee effective as of this date.

Please see the Company's Annual Report filed with the OTCQB Markets for further information.

About Capstone Holding Corp.

The Company's primary business activities presently include the operations of TotalStone, LLC, a construction materials company.

Capstone's corporate headquarters is located in Alsip, Illinois. For more information, please visit the Company's website: www.capstonethx.com.

Statements in this press release or otherwise attributable to Capstone regarding our business that are not historical facts are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. These risks include the factors discussed in our Annual Report for the fiscal year ended December 31, 2022, and other documents we filed with the U.S. Securities and Exchange Commission or OTCQB Markets.

FOR FURTHER INFORMATION:

Investor Relations
(708)371-0660
investorinquiries@capstonethx.com

SOURCE: Capstone Therapeutics Corp.



View the original press release on accesswire.com

© 2023 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.